Xeris Biopharma (XERS) CFO Steven Pieper Sells $42,500 in Shares

Steven Pieper, CFO of Xeris Biopharma (XERS), sold $42,500 worth of shares. This sale is notable as it may indicate the CFO's personal financial decisions, but does not inherently reflect the company's performance or outlook. Insider selling can sometimes raise questions among investors regarding a company's future. Understanding such transactions could inform investor sentiment and market behavior.